Quarterly ResultMay 7, 2026, 06:02 AM
Enovis Q1 Sales +5% to $589M; Reaffirms FY26 Guidance
AI Summary
Enovis Corporation announced its first-quarter 2026 financial results, reporting a 5% increase in net sales to $589 million on a reported basis, with organic growth of 3%. The Reconstructive segment showed strong performance, growing 11% reported and 6% organically, while the Prevention & Recovery segment was flat reported and grew 1% organically. Despite a net loss of $8 million, the company reiterated its full-year 2026 financial guidance for revenue, adjusted EBITDA, adjusted EPS, and free cash flow conversion, citing solid execution and momentum from new product introductions.
Key Highlights
- Enovis Q1 2026 net sales grew 5% reported to $589 million, and 3% organically.
- Reconstructive sales increased 11% on a reported basis and 6% organically in Q1.
- Prevention & Recovery (P&R) sales were flat reported and grew 1% organically in Q1.
- Q1 2026 net loss was $8 million, or $0.15 per share.
- Adjusted EBITDA for Q1 2026 was $104 million, or 17.6% of sales.
- Adjusted net earnings per diluted share for Q1 2026 was $0.89.
- Full-year 2026 revenue guidance reiterated at $2.31-2.37 billion, with 4-6% organic growth.
- Full-year adjusted EBITDA guidance reaffirmed at $425-435 million, and adjusted EPS at $3.52-$3.73.